CO157 Reductions in Acute Headache Medication Use after Eptinezumab Treatment in Patients with Chronic Migraines and Medication-Overuse Headache: Exploratory Analysis of PROMISE-2
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.250
https://www.valueinhealthjournal.com/article/S1098-3015(22)00451-X/fulltext
Title :
CO157 Reductions in Acute Headache Medication Use after Eptinezumab Treatment in Patients with Chronic Migraines and Medication-Overuse Headache: Exploratory Analysis of PROMISE-2
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00451-X&doi=10.1016/j.jval.2022.04.250
First page :
Section Title :
Open access? :
No
Section Order :
10218